FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081708912> ?p ?o ?g. }

• W2081708912 abstract "You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology III1 Apr 2015MP13-15 DO ANTIPLATELET AND ANTICOAGULANT INCREASE RISK OF HAEMORRHAGIC COMPLICATIONS IN PHOTOVAPORIZATION OF PROSTATE BY GREENLIGHT® LASER Pradère Benjamin, Peyronnet Benoit, Brichart Nicolas, and Bruyère Franck Pradère BenjaminPradère Benjamin More articles by this author , Peyronnet BenoitPeyronnet Benoit More articles by this author , Brichart NicolasBrichart Nicolas More articles by this author , and Bruyère FranckBruyère Franck More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.355AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Photoselective vaporization of prostate (PVP) is an alternative to transurethral resection of the prostate (TURP) particularly in patients with high risk of bleeding. The objective was to assess whether anticoagulants or antiplatelet intake in patients treated by PVP was associated with an increased risk of complications and to find risk factors for bleeding complications. METHODS All patients treated for benign prostate hyperplasia by PVP between November 2005 and January 2014 were included in a prospective study. According to the risk associated with the cessation of anticoagulant or antiplatelet for each patient, these treatments were stopped 5 days before surgery or continued. The frequency of haemorrhagic complications per and postoperative (bleeding requiring conversion to TURP, transfusion, clot removal, prolonged hematuria) in each group was compared by the Chi-2 test. Risk factors for bleeding complications per and postoperative were investigated by multivariate binary logistic regression. RESULTS Of 446 patients, 370 treated with PVP were analyzed, 17 (4.6%) had warfarin, 108 (29.2%) had aspirin and 16 (4.3%) clopidogrel. There were 39 hemorrhagic complications (10.5%). In univariate analysis, no significant differences were found on the incidence of bleeding complications between the groups anticoagulants continued, anticoagulants stopped and no anticoagulants (17.6% vs 10.5% vs 9.8%, p= 0.49); the results were similar with antiplatelet agents, respectively (14.8% vs 6.5% vs 9.1%, p = 0.21) for aspirin and (6.3% vs 14.8% vs 10%, p= 0.48) for clopidogrel. The use of anticoagulants or antiplatelet agents was not a factor in bleeding risk in multivariate analysis, the only risk factor was the low energy applied in joules/grams of prostate (OR= 0.95, IC95= [0.91 -0.98], p= 0.004). Four vascular complications occurred: three acute coronary syndromes including two patients for whom aspirin was stopped, and one phlebitis in a patient for whom a relay warfarin to low molecule weight heparin was performed. CONCLUSIONS The pursuit of anticoagulants or antiplatelet agents do not appear to increase the risk of bleeding complications in PVP. Their stopping for the intervention increases the risk of serious vascular accidents. We must therefore continue to perform these treatments during PVP procedure. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e142 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Pradère Benjamin More articles by this author Peyronnet Benoit More articles by this author Brichart Nicolas More articles by this author Bruyère Franck More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ..." @default.
• W2081708912 created "2016-06-24" @default.
• W2081708912 creator A5025338168 @default.
• W2081708912 creator A5038866794 @default.
• W2081708912 creator A5039823257 @default.
• W2081708912 creator A5064810269 @default.
• W2081708912 date "2015-04-01" @default.
• W2081708912 modified "2023-09-22" @default.
• W2081708912 title "MP13-15 DO ANTIPLATELET AND ANTICOAGULANT INCREASE RISK OF HAEMORRHAGIC COMPLICATIONS IN PHOTOVAPORIZATION OF PROSTATE BY GREENLIGHT® LASER" @default.
• W2081708912 doi "https://doi.org/10.1016/j.juro.2015.02.355" @default.
• W2081708912 hasPublicationYear "2015" @default.
• W2081708912 type Work @default.
• W2081708912 sameAs 2081708912 @default.
• W2081708912 citedByCount "0" @default.
• W2081708912 crossrefType "journal-article" @default.
• W2081708912 hasAuthorship W2081708912A5025338168 @default.
• W2081708912 hasAuthorship W2081708912A5038866794 @default.
• W2081708912 hasAuthorship W2081708912A5039823257 @default.
• W2081708912 hasAuthorship W2081708912A5064810269 @default.
• W2081708912 hasConcept C121608353 @default.
• W2081708912 hasConcept C126322002 @default.
• W2081708912 hasConcept C126894567 @default.
• W2081708912 hasConcept C141071460 @default.
• W2081708912 hasConcept C2776235491 @default.
• W2081708912 hasConcept C2777562237 @default.
• W2081708912 hasConcept C2778205648 @default.
• W2081708912 hasConcept C2780768273 @default.
• W2081708912 hasConcept C71924100 @default.
• W2081708912 hasConceptScore W2081708912C121608353 @default.
• W2081708912 hasConceptScore W2081708912C126322002 @default.
• W2081708912 hasConceptScore W2081708912C126894567 @default.
• W2081708912 hasConceptScore W2081708912C141071460 @default.
• W2081708912 hasConceptScore W2081708912C2776235491 @default.
• W2081708912 hasConceptScore W2081708912C2777562237 @default.
• W2081708912 hasConceptScore W2081708912C2778205648 @default.
• W2081708912 hasConceptScore W2081708912C2780768273 @default.
• W2081708912 hasConceptScore W2081708912C71924100 @default.
• W2081708912 hasIssue "4S" @default.
• W2081708912 hasLocation W20817089121 @default.
• W2081708912 hasOpenAccess W2081708912 @default.
• W2081708912 hasPrimaryLocation W20817089121 @default.
• W2081708912 hasRelatedWork W1945259997 @default.
• W2081708912 hasRelatedWork W1996232388 @default.
• W2081708912 hasRelatedWork W2000394890 @default.
• W2081708912 hasRelatedWork W2032223225 @default.
• W2081708912 hasRelatedWork W2048915257 @default.
• W2081708912 hasRelatedWork W2283498514 @default.
• W2081708912 hasRelatedWork W2325727761 @default.
• W2081708912 hasRelatedWork W2383305874 @default.
• W2081708912 hasRelatedWork W3017099235 @default.
• W2081708912 hasRelatedWork W2187004699 @default.
• W2081708912 hasVolume "193" @default.
• W2081708912 isParatext "false" @default.
• W2081708912 isRetracted "false" @default.
• W2081708912 magId "2081708912" @default.
• W2081708912 workType "article" @default.